1887

Abstract

Human herpesvirus-8 (HHV-8), a gammaherpesvirus that is thought to be the viral aetiologic agent of Kaposi’s sarcoma and primary effusion lymphoma, encodes a homologue to cellular interferon regulatory factors (IRFs). The HHV-8 IRF homologue (vIRF; ORF K9) has previously been shown to inhibit gene induction by interferons and IRF-1 and to transform NIH3T3 cells or Rat-1 cells. Additionally, expression of antisense to vIRF in BCBL-1 cells results in the repression of certain HHV-8 genes, suggesting that vIRF may also positively regulate gene expression. We demonstrate that vIRF activates transcription when directed to DNA by the GAL4 DNA-binding domain. GAL-vIRF truncation constructs that individually are incapable of activating transcription can cooperate in transactivation when coexpressed in HeLa cells, suggesting that multiple regions of vIRF are involved in transactivation. These studies broaden the potential mechanisms of action of vIRF to include transcriptional activation as well as transcriptional repression.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-8-2205
1999-08-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/8/0802205a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-8-2205&mimeType=html&fmt=ahah

References

  1. Carey M., Kakidani H., Leatherwood J., Mostashari F., Ptashne M. 1989; An amino-terminal fragment of GAL4 binds DNA as a dimer. Journal of Molecular Biology 209:423–432
    [Google Scholar]
  2. Flint J., Shenk T. 1997; Viral transactivating proteins. Annual Review of Genetics 31:177–212
    [Google Scholar]
  3. Fujita T., Sakakibara J., Sudo Y., Miyamoto M., Kimura Y., Taniguchi T. 1988; Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO Journal 7:3397–3405
    [Google Scholar]
  4. Fujita T., Reis L. F., Watanabe N., Kimura Y., Taniguchi T., Vilcek J. 1989; Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proceedings of the National Academy of Sciences, USA 86:9936–9940
    [Google Scholar]
  5. Gao S. J., Boshoff C., Jayachandra S., Weiss R. A., Chang Y., Moore P. S. 1997; KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979–1985
    [Google Scholar]
  6. Goodbourn S. 1996; Eukaryotic gene transcription. In Frontiers in Molecular Biology pp 292 New York: IRL Press;
    [Google Scholar]
  7. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. 1989; Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729–739
    [Google Scholar]
  8. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M., Taniguchi T. 1993; Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259:971–974
    [Google Scholar]
  9. Harada H., Takahashi E., Itoh S., Harada K., Hori T. A., Taniguchi T. 1994; Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Molecular and Cellular Biology 14:1500–1509
    [Google Scholar]
  10. Kingston R., Sheen J. 1997; Phase-extraction assay for CAT activity. In Current Protocols in Molecular Biology pp. 9.7.5–9.7.11 Edited by Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman G. J., Smith J. A., Struhl K. New York: John Wiley;
    [Google Scholar]
  11. Li M., Lee H., Guo J., Neipel F., Fleckenstein B., Ozato K., Jung J. U. 1998; Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor. Journal of Virology 72:5433–5440
    [Google Scholar]
  12. Marmorstein R., Carey M., Ptashne M., Harrison S. C. 1992; DNA recognition by GAL4: structure of a protein–DNA complex. Nature 356:408–414
    [Google Scholar]
  13. Moore P. S., Boshoff C., Weiss R. A., Chang Y. 1996; Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–1744
    [Google Scholar]
  14. Nguyen H., Mustafa A., Hiscott J., Lin R. 1995; Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain. Oncogene 11:537–544
    [Google Scholar]
  15. Reis L. F., Harada H., Wolchok J. D., Taniguchi T., Vilcek J. 1992; Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO Journal 11:185–193
    [Google Scholar]
  16. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y., Moore P. S. 1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8. Proceedings of the National Academy of Sciences, USA 93:14862–14867
    [Google Scholar]
  17. Tanaka N., Kawakami T., Taniguchi T. 1993; Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Molecular & Cellular Biology 13:4531–4538
    [Google Scholar]
  18. Taniguchi T., Harada H., Lamphier M. 1995; Regulation of the interferon system and cell growth by the IRF transcription factors. Journal of Cancer Research & Clinical Oncology 121:516–520
    [Google Scholar]
  19. Zimring J. C., Goodbourn S., Offermann M. K. 1998; Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. Journal of Virology 72:701–707
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-8-2205
Loading
/content/journal/jgv/10.1099/0022-1317-80-8-2205
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error